Colin Law

Mr. Law is a partner in Fangda’s Hong Kong office. His practice focuses on capital markets and securities transactions. His experience includes advising bulge bracket US investment banks and Chinese companies on international public offerings, takeovers of public companies, privatization and regulatory matters. He is particularly involved in the healthcare, biotech and media sectors. Colin serves on the board of Hong Kong Biomedical Development Advisory Panel. He has wide experience representing top- notch international financial institutions including bank of America Merrill Lynch, CitiGroup, Goldman Sachs and Morgan Stanley.